Skip to main content
SpringerLink
Log in

Infectious diseases

Integrating vaccines and monoclonal antibodies into malaria prevention

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Two malaria vaccines are approved and several prophylactic antibodies are in development, but a combination of strategies tailored to different epidemiological situations will be needed if malaria is to be eliminated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: The malaria life cycle and targets for monoclonal antibodies.

References

  1. World Health Organization. WHO Guidelines for Malaria 2023 https://go.nature.com/48zjClh (2023).

  2. Nussenzweig, R. et al. Mil. Med. 134, 1176–1182 (1969).

    Article  CAS  PubMed  Google Scholar 

  3. Clyde, D. F. et al. Am. J. Med. Sci. 266, 169–177 (1973).

    Article  CAS  PubMed  Google Scholar 

  4. Gaudinski, M. R. et al. N. Engl. J. Med. 385, 803–814 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wu, R. L. et al. N. Engl. J. Med. 387, 397–407 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kayentao, K. et al. N. Engl. J. Med. 377, 1833–1842 (2022).

    Article  Google Scholar 

  7. Williams, K. L. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02659-z (2024).

    Article  PubMed  Google Scholar 

  8. Regules, J. A. et al. J. Infect. Dis. 214, 732–772 (2016).

    Article  Google Scholar 

  9. World Health Organization. World Malaria Report 2023 https://go.nature.com/48ummR6 (2023).

  10. Kapulu, M. C. et al. JCI Insight 6, e146443 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  11. World Health Organizaton. Monoclonal Antibodies for Malaria Prevention https://go.nature.com/3RLKwj0 (2023).

  12. Stanisic, D. I. et al. BioDrugs 37, 737–756 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA

    Terrie E. Taylor

  2. Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi

    Terrie E. Taylor

  3. Department of Life Sciences, Imperial College London, London, UK

    Faith Osier

Authors
  1. Terrie E. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faith Osier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Terrie E. Taylor.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, T.E., Osier, F. Integrating vaccines and monoclonal antibodies into malaria prevention. Nat Med 30, 37–38 (2024). https://doi.org/10.1038/s41591-023-02745-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02745-2

  • Springer Nature America, Inc.

Search

Navigation